AU2001266392A1 - The controlled release preparation of insulin and its method - Google Patents

The controlled release preparation of insulin and its method

Info

Publication number
AU2001266392A1
AU2001266392A1 AU2001266392A AU6639201A AU2001266392A1 AU 2001266392 A1 AU2001266392 A1 AU 2001266392A1 AU 2001266392 A AU2001266392 A AU 2001266392A AU 6639201 A AU6639201 A AU 6639201A AU 2001266392 A1 AU2001266392 A1 AU 2001266392A1
Authority
AU
Australia
Prior art keywords
insulin
controlled release
release preparation
preparation
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266392A
Other languages
English (en)
Inventor
Sung-Hee Choi
Chan-Hwa Kim
Jai-Hyun Kwon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MI Tech Co Ltd
Original Assignee
MI Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020000085698A external-priority patent/KR100342746B1/ko
Application filed by MI Tech Co Ltd filed Critical MI Tech Co Ltd
Publication of AU2001266392A1 publication Critical patent/AU2001266392A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001266392A 2000-06-27 2001-06-25 The controlled release preparation of insulin and its method Abandoned AU2001266392A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
KR20000035760 2000-06-27
KR2000/35760 2000-06-27
KR1020000085698A KR100342746B1 (ko) 2000-06-27 2000-12-29 인슐린의 방출제어제제 및 그 방법
KR2000/85698 2000-12-29
PCT/KR2001/001085 WO2002000207A1 (fr) 2000-06-27 2001-06-25 Preparation d'insuline a liberation lente et procede de production associe

Publications (1)

Publication Number Publication Date
AU2001266392A1 true AU2001266392A1 (en) 2002-01-08

Family

ID=26638148

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266392A Abandoned AU2001266392A1 (en) 2000-06-27 2001-06-25 The controlled release preparation of insulin and its method

Country Status (6)

Country Link
US (1) US7087246B2 (fr)
EP (1) EP1296660A4 (fr)
JP (1) JP2004501188A (fr)
CN (1) CN100345535C (fr)
AU (1) AU2001266392A1 (fr)
WO (1) WO2002000207A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1663469A4 (fr) * 2003-09-05 2009-01-07 Univ Massachusetts Capsules polymeres amphiphiles et procedes associes d'assemblage interfacial
EP2626368B1 (fr) * 2004-07-19 2016-12-21 Biocon Limited Conjugués insuline-oligomère, formulations et utilisations de ceux-ci
AU2006221364A1 (en) * 2005-03-09 2006-09-14 Ono Pharmaceutical Co., Ltd. Particle and preparation containing the particle
RU2457854C2 (ru) * 2005-12-30 2012-08-10 Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи Лимитед Длительное высвобождение нейрегулина для улучшения сердечной функции
KR100853309B1 (ko) * 2006-11-01 2008-08-20 나재운 시프로플록사신이 담지된 폴리락타이드글리콜라이드공중합체의 서방출 및 생분해성 나노입자 및 그 제조방법
KR101034888B1 (ko) * 2007-04-19 2011-05-17 동아제약주식회사 지속제어 방출 양상을 갖는 당조절 펩타이드 함유 생분해성고분자 미립구 및 그 제조방법
US8685458B2 (en) 2009-03-05 2014-04-01 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives
JP5491119B2 (ja) * 2009-10-02 2014-05-14 日東電工株式会社 薬物含有微粒子を含む医薬組成物およびその製造方法
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
CN102144976A (zh) * 2011-01-19 2011-08-10 谢坤 用“微胶囊”技术制备口服胰岛素干粉的方法
US9060938B2 (en) 2011-05-10 2015-06-23 Bend Research, Inc. Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
BRPI1103164A2 (pt) * 2011-06-13 2013-07-23 Univ Rio De Janeiro sistema polimÉrico de confinamento de insulina, processo e uso de dito sistema
RU2014120626A (ru) * 2014-05-22 2015-11-27 Владимир Андреевич Сабецкий Инсулинсодержащий препарат пролонгированного действия
BR112017000175B1 (pt) 2014-07-08 2023-11-21 Amphastar Pharmaceuticals,Inc. Método de preparação de uma insulina inalável adequada para a liberação pulmonar e partículas de insulina micronizadas
US10322168B2 (en) 2016-01-07 2019-06-18 Amphastar Pharmaceuticals, Inc. High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
GB201622024D0 (en) * 2016-11-14 2017-02-08 Inventage Lab Inc Apparatus and method for large scale production of monodisperse, microsheric and biodegradable polymer-based drug delivery
CN108553639B (zh) * 2018-04-25 2022-04-19 福州大学 一种壳聚糖/胰岛素纳米缓释经皮制剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE35862E (en) * 1986-08-18 1998-07-28 Emisphere Technologies, Inc. Delivery systems for pharmacological agents encapsulated with proteinoids
GB9116610D0 (en) * 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
CN1098026A (zh) * 1993-07-30 1995-02-01 吴道澄 半连续乳液聚合法制备氰基丙烯酸酯毫微囊
JP4117922B2 (ja) 1996-03-28 2008-07-16 武田薬品工業株式会社 徐放性製剤およびその製造法
CN1075945C (zh) * 1998-02-26 2001-12-12 中国科学院化学研究所 一种高分子包囊胰岛素微粒体及其制备方法和用途
EP2311436A1 (fr) * 1998-04-27 2011-04-20 Altus Pharmaceuticals Inc. Cristaux de protéines stabilisées, formulations renfermant lesdits cristaux et leurs procèdes de fabrication
CN1253018A (zh) * 1998-11-03 2000-05-17 中国医学科学院生物医学工程研究所 胰岛素纳米粒子及制备方法
KR100327597B1 (ko) * 1999-04-27 2002-03-07 김찬화 인슐린의 균일한 미세 결정(ｃｒｙｓｔａｌ)의 제조 방법
WO2001000654A2 (fr) * 1999-06-29 2001-01-04 Pharmaceutical Discovery Corporation Purification et stabilisation de produits pharmaceutiques a base de peptides et de proteines

Also Published As

Publication number Publication date
WO2002000207A9 (fr) 2005-07-21
WO2002000207A1 (fr) 2002-01-03
JP2004501188A (ja) 2004-01-15
US7087246B2 (en) 2006-08-08
EP1296660A1 (fr) 2003-04-02
CN100345535C (zh) 2007-10-31
CN1438881A (zh) 2003-08-27
US20030125237A1 (en) 2003-07-03
EP1296660A4 (fr) 2005-04-13

Similar Documents

Publication Publication Date Title
AU2001286677A1 (en) Controlled release of substances
AU2001290825A1 (en) Controlled release formulations and methods for their production and use
AU2002227414A1 (en) Infusion devices and method
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001253411A1 (en) Medical dressing assembly and associated method of using the same
IL186782A0 (en) Controlled release composition and method of producing the same
AU2002224079A1 (en) O/W emulsion composition and method of preparing the same
AU2001266392A1 (en) The controlled release preparation of insulin and its method
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2000266079A1 (en) Chitosan and method of preparing chitosan
AU2001245288A1 (en) Overhanging form system and method of using the same
AU2001256373A1 (en) Syringe and method for the use thereof
AU2002215014A1 (en) Method and device for the preparation of fuels
AU2001260774A1 (en) Bio-support and preparing method of the same
AU4213299A (en) Controlled release of substances
AU5116100A (en) Connector and method of use of the connector
AU2001232948A1 (en) Controlled release of drugs
AU2002224035A1 (en) Composite element and method for preparation thereof
AU2002228801A1 (en) Post-crepe stabilized material and method of producing the same
AU2002230413A1 (en) Pigment dispersion and method of preparing the same
AU2001261375A1 (en) Human caspase-12 materials and methods
AU2001295672A1 (en) Vaccine composition and stabilisation method
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2003215947A1 (en) Controlled release composition comprising felodipine and method of preparation thereof
AU2001280079A1 (en) Method of safe infusion